This Article Full Text Full Text (PDF) All Versions of this Article: 26/5/1114    most recent 01.ATV.0000217747.66517.11v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koch, W. Articles by Kastrati, A. Search for Related Content PubMed PubMed Citation Articles by Koch, W. Articles by Kastrati, A.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1114.)
© 2006 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Association of Transforming Growth Factor-ß1 Gene Polymorphisms With Myocardial Infarction in Patients With Angiographically Proven Coronary Heart Disease

Werner Koch; Petra Hoppmann; Jakob C. Mueller; Albert Schömig; Adnan Kastrati

From Deutsches Herzzentrum München and 1. Medizinische Klinik (W.K., P.H., A.S., A.K.), Klinikum rechts der Isar, Technische Universität München, Munich; Institut für medizinische Statistik und Epidemiologie and Institut für Psychologie und Psychotherapie (J.C.M.), Klinikum rechts der Isar, Technische Universität München, Munich; and Hertie-Institut für klinische Hirnforschung, Tübingen, Germany.

Correspondence to Dr Werner Koch, Deutsches Herzzentrum München, Lazarettstrasse 36, 80636 München, Germany. E-mail wkoch{at}dhm.mhn.de

Objective— Transforming growth factor (TGF)-ß1 (TGF-ß1) is a multifunctional cytokine that exhibits vasculoprotective properties. Production and plasma levels of TGF-ß1 are influenced by polymorphisms in the TGF-ß1 gene (TGFB1). We investigated whether the –509C/T (rs1800469), 868T/C (rs1982073), 913G/C (rs1800471), and 11929C/T (rs1800472) polymorphisms of TGFB1 are associated with myocardial infarction.

Methods and Results— The study population consisted of 3657 patients with myocardial infarction (885 women and 2772 men) and 1211 control individuals (598 women and 613 men) with angiographically normal coronary arteries and without signs or symptoms of myocardial infarction. Polymorphism-related genotypes were determined with TaqMan assays and haplotypes were estimated from the genotype data. The –509C/T polymorphism and –509C/868T/913G/11929C (CTGC) haplotype were associated with myocardial infarction in men, independently from the potentially confounding factors age, arterial hypertension, hypercholesterolemia, cigarette smoking, and diabetes mellitus. Lower risks of myocardial infarction were observed among the carriers of the –509CC genotype (adjusted odds ratio [OR], 0.49; 95% confidence interval [CI], 0.27 to 0.87; P=0.014) and homozygous carriers of the CTGC haplotype (adjusted OR, 0.61; 95% CI, 0.38 to 0.98; P=0.042) than among the noncarriers of this genotype or haplotype. None of the genotypes (P0.37) or haplotypes (P0.35) was associated with myocardial infarction in women.

Conclusions— Positive association findings in this study suggest that TGFB1 is a susceptibility locus for myocardial infarction.

We investigated the association of 4 single nucleotide polymorphisms of the TGF-ß1 gene with myocardial infarction in a large white population. The results show that one of the polymorphisms (–509C/T) and a specific haplotype (CTGC haplotype) were associated with myocardial infarction in men but not in women.

Key Words: haplotype • myocardial infarction • TGFB1 • transforming growth factor-ß1 • SNP

This article has been cited by other articles:

				D. J. Grainger TGF-{beta} and atherosclerosis in man Cardiovasc Res, May 1, 2007; 74(2): 213 - 222. [Abstract] [Full Text] [PDF]